-
potassium (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-({[(hydrogen phosphonatooxy)(hydroxy)phosphoryl]oxy}methyl)oxolane-3,4-diol
-
ChemBase ID:
103004
-
Molecular Formular:
C10H14KN5O10P2
-
Molecular Mass:
465.291482
-
Monoisotopic Mass:
464.98529661
-
SMILES and InChIs
SMILES:
Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)([O-])O)[C@@H](O)[C@H]1O.[K+]
Canonical SMILES:
O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)[O-])O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N.[K+]
InChI:
InChI=1S/C10H15N5O10P2.K/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20;/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20);/q;+1/p-1/t4-,6-,7-,10-;/m1./s1
InChIKey:
ZNCWUOPIJTUALR-MCDZGGTQSA-M
-
Cite this record
CBID:103004 http://www.chembase.cn/molecule-103004.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
potassium (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-({[(hydrogen phosphonatooxy)(hydroxy)phosphoryl]oxy}methyl)oxolane-3,4-diol
|
|
|
|
|
IUPAC Traditional name
|
|
potassium (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-({[hydrogen phosphonatooxy(hydroxy)phosphoryl]oxy}methyl)oxolane-3,4-diol
|
|
|
|
|
Synonyms
|
|
ADP-K
|
|
ADENOSINE-5'-DIPHOSPHATE MONOPOTASSIUM SALT
|
|
ADP
|
|
Adenosine 5′-diphosphate monopotassium salt dihydrate
|
|
Adenosine 5′-diphosphate 单钾盐 二水合物
|
|
|
|
|
CAS Number
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
1.7714787
|
H Acceptors
|
12
|
H Donor
|
5
|
LogD (pH = 5.5)
|
-7.1348915
|
LogD (pH = 7.4)
|
-7.671735
|
Log P
|
-4.982523
|
Molar Refractivity
|
83.8197 cm3
|
Polarizability
|
33.73472 Å3
|
Polar Surface Area
|
235.43 Å2
|
Rotatable Bonds
|
6
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
MP Biomedicals
Sigma Aldrich
Sigma Aldrich -
A5285
|
Biochem/physiol Actions P2Y receptor agonist. Application Adenosine 5′-diphosphate is a P2Y receptor agonist. Adenosine 5′-diphosphate has been used to study the release, neuronal effects and removal of extracellular β-nicotinamide adenine dinucleotide (β-NAD+) in the rat brain. Adenosine 5′-diphosphate has also been used to compare prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome. |
PATENTS
PATENTS
PubChem Patent
Google Patent